STAT Plus: Biotech venture capital had a record-breaking quarter, but isn’t out of the woods yet
A version of this story also appeared in STAT’s daily biotech newsletter, The Readout. Subscribe here.
Biotech venture capitalists and their portfolio companies had a historic first quarter — but that doesn’t mean the industry is out of the woods just yet.
